There were 1,650 press releases posted in the last 24 hours and 454,512 in the last 365 days.

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Size to Surpass US$ 205 Million by 2030 - Growth Plus Reports

/EIN News/ -- Newark, New Castle, USA, March 23, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global small intestinal bacterial overgrowth (SIBO) diagnostics market is expected to clock US$ 205 million by 2030 and to grow at a CAGR of 4.3% during the forecast period. Owing to new diagnostic practices introduced in the market. This exclusive information is published by Growth Plus Reports in its report titled “Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Global Outlook & Forecast 2022-2030”

Request a Sample Copy of the Research Report:

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Scope

Report Attribute Details
Market size value in 2021 US$ 140 million
Revenue forecast in 2030 US$ 205 million
Growth Rate CAGR of 4.3% from 2022 to 2030
Base year for estimation 2021
Forecast period 2022-2030
Historical Year 2020
Segments covered Method, Type, and Region.
Regional scope North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Growth Drivers

As gastrointestinal issues are increasing significantly, the development of innovative diagnostic kits is highly increasing. For instance, The trio-smart breath test is appropriate for individuals with bloating, gas, stomach pain, constipation, or diarrhea. Trio-smart analyses breath for amounts of hydrogen, methane, and hydrogen sulfide. Elevated gas levels may signal intestinal methanogenic overgrowth (IMO), excess hydrogen sulfide, or small intestinal bacterial overgrowth (SIBO). The trio-smart breath test results are the first step toward feeling better and can help guide appropriate treatment.

Similarly, Life Extension offers a kit that includes a lactulose solution. Methane and/or hydrogen gas are produced during the fermentation of this sugar. The unique benefit of this SIBO test is that it measures both gases, which may be a sign of SIBO. The benefit of lactulose is that it can identify bacterial overgrowth anywhere in the small intestine, including the bottom part, where it most frequently occurs. Only bacteria have the necessary enzymes to break down and absorb lactulose; humans lack these enzymes. Lactulose travels the whole length of the gut since it is not absorbed, demonstrating SIBO at all intestine segments.

The global small intestinal bacterial overgrowth (SIBO) diagnostics market is divided into three perspectives: Method, Type, and Region. 

Excerpts from ‘By Diagnosis’

Based on diagnosis, the global small intestine bacterial overgrowth (SIBO) diagnostics market is segmented into:

  • Breath Testing
  • Malabsorption Tests
  • Small Intestine Aspirate
  • Fluid Culture Test
  • Blood Tests
  • Others

The breath testing segment has dominated the global small intestinal bacterial overgrowth. The breath testing segment is again segmented into xylose breath, hydrogen breath test, and glycocholic acid breath. The hydrogen breath test is the most demanding breath test. Moreover, the hydrogen breath test provides appropriate results. It is considered one of the most reliable and validated diagnostic techniques for small intestinal bacterial overgrowth (SIBO) diagnostics.

Excerpts from ‘By Type’

Based on type, the global small intestinal bacterial overgrowth (SIBO) diagnostics market is grouped into:

  • Hydrogen-Predominant SIBO
  • Methane-Predominant SIBO
  • Recurrent SIBO

The hydrogen-predominant SIBO had the biggest market share in 2021, and the same segment is anticipated to expand at the fastest rate in the forecast years. Hydrogen-predominant small intestinal bacterial overgrowth (SIBO) is most common due to increased dietary sugar intake and processed foods. These foods provide an ideal environment for bacterial growth and can cause an overgrowth of bacteria in the small intestine leading to loss of appetite, discomfort, and bloating. Moreover, Imbalances in gut bacteria can also be caused by age, antibiotic use, and digestive disorders such as irritable bowel syndrome.

Request for Customization –

Excerpts from ‘By Region’

The small intestinal bacterial overgrowth (SIBO) market has been divided into four regions based on geography:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

North America has the largest small intestinal bacterial overgrowth (SIBO) diagnostics market. The prevalence of small intestinal bacterial overgrowth (SIBO) is increasing in North America due to several factors. These include dietary changes, increased use of antibiotics, changes in gut microbiota, and the disruption of the balance between bacteria and fungi. Additionally, certain lifestyle factors, such as increased stress levels, can contribute to the development of SIBO. Technological advancements in the region support the Asia Pacific small intestinal bacterial overgrowth (SIBO) diagnostics market. The conventional diagnostic techniques previously used to diagnose various gastrointestinal illnesses have been replaced due to recent technological advancements in creating solid-state and electromechanical sensors. Incidences of lactose malabsorption are on the rise, and the population in the region is becoming more aware of its health, which will likely result in the growth of the small intestinal bacterial overgrowth (SIBO) diagnostics market.

Excerpts from ‘Competitive Landscape’

Some of the prominent players operating in the global small intestinal bacterial overgrowth (SIBO) diagnostics market are:

  • Genova Diagnostics
  • SIBO diagnostics
  • Commonwealth Diagnostics International
  • Aerodiagnostics, LLC
  • Pivotal Diagnostics
  • DirectLabs, LLC
  • Health Associates Medical Group
  • Vibrant Wellness
  • Metabolic Solutions, Inc.

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecast Years – 2022 to 2030
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trend (COVID-19 Perspective)
    2. Technological Trends
    3. Key Players & Competitive Positioning (2021)
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Breath Testing 
      1. Xylose Breath Testing 
      2. Hydrogen Breath Testing 
      3. Glycocholic Acid Breath Testing 
    2. Malabsorption Tests 
    3. Small Intestine Aspirate and Fluid Culture Test 
    4. Blood Test 
    5. Others 

TOC Continued..

Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Schedule a call with our analyst:

Visit our report store at -

Browse related reports:

Hydrogel Dressing Market by Product Type (Impregnated Hydrogel, Amorphous Hydrogel), Application (Chronic Wounds, Acute Wounds), Raw Material (Synthetic, Natural), End User (Hospitals, Homecare) - Global Outlook & Forecast 2022-2030

IV Therapy and Vein Access Devices Market by Type (Infusion Pumps, Implantable Ports), Application (Volume Expander, Blood-based Products,) End User (Hospitals, Ambulatory Surgical Centers) – Global Outlook & Forecast 2022-2030

Connected Healthcare Market by Type (mHealth Devices, mHealth Services), Function (Assisted Living, Home Monitoring), Application (Healthcare Management, Wellness & Prevention, Diagnosis & Treatment)-Global Outlook & Forecast 2022-2030

Uterine Fibroids Treatment Devices Market by Technology, (Surgical Techniques, Laparoscopic Techniques, Ablation Technique), Treatment (Invasive Treatment, Non-Invasive Treatment) – Global Outlook & Forecast 2022-2030

Coronary Artery Bypass Graft Devices Market by Techniques (On-Pump CABG, Off-Pump CABG), Device Types (Tissue Stabilizers, Endoscopic Vessel Harvesting Systems), End-user (Hospitals, Others) – Global Outlook & Forecast 2022-2030

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Manan Sethi
Director, Market Insights
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009

Primary Logo